FDA gives drugmakers new ways to prove opioid disorder treatments work

The FDA has noticeably shifted its approach to drug approval, releasing new recommendations that give drug developers a wider array of outcome measures to prove the efficacy of new medication-assisted treatments for opioid use disorder.

Read the full post at Modern Healthcare Breaking News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive